Curious about what else BCC's AI Reports cover?
Get complimentary access to VerticalContext Chat.
Report Highlights
This report provides a brief overview of AI impact on the global cell and gene therapy (CGT) tools and reagents market. It highlights major adoption trends across the key geographic regions, and disruptions caused across several key industry verticals.
Report Includes
- Impact analysis of artificial intelligence (AI) on the global market for cell and gene therapy (CGT) tools and reagents
- Case studies for successful integration of AI and automation in accelerated drug discovery, optimized clinical trials and personalized treatments
- Highlights of AI adoption trends across the major geographical regions as well as disruptions caused by AI across key industry verticals
- Review of AI impact on the various stages of the global supply chain analysis
- Competitive landscape featuring strategic initiatives, market spendings and VC funding outlook
Report Scope
The number of cell and gene therapy (CGT) products approved by the U.S. Food and Drug Administration (FDA) has increased each year, driving up demand for CGT. The intricacy of CGT has proven difficult for conventional software systems to handle, despite advances in drug discovery and therapy development. Conventional software frequently lacks the intelligence and adaptability needed to manage the complexities of CGT. Cell and gene therapy-specific AI platforms can manage complex biological data. AI tools help manufacturers and scientists navigate the complexity of CGT more accurately and efficiently.
Recent Reports
AI Impact on Mental Health Disorders Treatment Market - BCC Pulse Report
This report provides an outlook of artificial intelligence impact on the global mental health disorders treatment market. It highlights major adoption trends of across the key geographic regions, and a review of market disruptions caused across several key industry verticals.
AI Impact on Virtual and Augmented Reality Market - BCC Pulse Report
The report explores how AI is making augmented reality (AR) and virtual reality (VR) experiences more personalized and interactive. It covers the use of AI to adapt content based on user preferences and behavior across healthcare, training, gaming, and retail. The report also highlights the role of generative AI in creating dynamic environments, characters, and events to improve user engagement and enhance immersive experiences.
Global Market for AI In Waste Management
The global market for AI in waste management is expected to grow from $48.1 billion in 2026 and is projected to reach $85.8 billion by the end of 2031, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2026 to 2031.
State of the Artificial Intelligence Technology (AIT) Industry - 2026 Third Quarter Review
During the third quarter of 2026, artificial intelligence (AI) continued to expand across business operations as organizations moved beyond standalone applications toward broader workflow integration. Enterprises increasingly adopted AI assistants, automation platforms, agents, and industry-specific solutions to improve productivity, decision-making, customer experience, and operational efficiency. This growing adoption also accelerated investment in cloud computing, AI infrastructure, data platforms, and networking, while increasing the focus on data quality, security, governance, scalability, and measurable business outcomes.
AI Impact on 3D Printing Drugs - BCC Pulse Report
This report provides an outlook of artificial intelligence impact on the global 3D printing drugs market. It highlights major adoption trends of across the key geographic regions, and a review of market disruptions caused across several key industry verticals.
Top Trending Reports
Bioinformatics: Technologies and Global Markets
The global bioinformatics market was valued at $23.5 billion in 2025 and is estimated to reach $43.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Global Enterprise Artificial Intelligence (AI) Market
This study examines the global enterprise AI market across key segments such as component, software deployment, technology, organization size, end user and geography. It focuses on commercially deployed AI software, services and hardware generating revenue across industries, including new deployments and the expansion of existing AI infrastructure. The analysis also covers emerging technologies, major market trends and challenges, the competitive landscape and profiles of leading companies. Regional market trends are assessed using 2025 as the base year, with forecasts from 2026 through 2031.
Outpatient Surgical Procedures: Global Markets
The global market for outpatient surgical procedures is expected to grow from $381.9 billion in 2026 and is projected to reach $598.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2026 to 2031.
Global Vaccine Adjuvants Market
This report provides an analysis of the global market for vaccine adjuvants. It focuses on the key driving trends and challenges. The study evaluates the competitive landscape, reviews key technological developments, and provides market estimates and forecasts through 2031.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More